US Patent Issued to ELI LILLY and Co. on June 17 for "Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin" (Canadian Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,762, issued on June 17, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin" was invented by Jean-Luc Ardilouze (Sherbrooke, Canada), Maude Gagnon-Auger (Sherbrooke, Canada), Fernand Gobeil (Sherbrooke, Canada), Julie Menard (Sherbrooke, Canada), Jean-Patrice Baillargeon (Sherbrooke, Canada) and Pascal Brassard (Magog, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and combinations comprising one or more insulin(s) and one or more vasoactive agent(s), and use thereof for increasing subcutaneous ...